Q-omics provides the consensus-scored MIR7845 profile across patient tissues and cancer cell-line models. MIR7845 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, MIR7845 is differentially expressed in 4, with the highest sampling consensus in HNSC. Additionally, MIR7845 RNA expression shows 5,557 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRP, HNSC, and STAD as cancer lineages where MIR7845 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR7845 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR7845 survival associations across molecular data types. MIR7845 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR7845 RNA expression–survival associations across cancer types. High MIR7845 expression shows unfavorable associations in KIRP, HNSC, BRCA, ACC, THCA and KIRC. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for MIR7845 RNA expression.
This table summarizes MIR7845 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR7845. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR7845 shows lower tumor expression in THCA, KIRC and KICH and higher tumor expression in HNSC. The HNSC box plot shows higher MIR7845 RNA expression in tumor versus normal tissue (log2 FC = +0.257, t-test p = .010).
This table shows molecular features associated with MIR7845 in patient tissues and cancer cell lines. In patient samples, MIR7845 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
